Non-life premiums of the sector have grown at 17 per cent annually over the FY12-17 to Rs 1.28 lakh crore. The is projected to more than double to Rs 3 lakh crore by FY22, growing annually at 15-20 per cent, according to estimates by CRISIL and the Insurance Regulatory and Development Authority of India. This should also reflect positively on the Indian reinsurance market, just under Rs 40,000 crore and expected to grow at an annual 11-14 per cent to Rs 70,000 crore by FY22.
This, with robust yields on investment and a diversified book, both in terms of segments GIC Re caters to as well as the geographies, helps mitigate risk. While the company underwrites risk in eight segments, the India business contributes 55-69 per cent of premium, the rest coming from operations outside the country. Its overseas operations are also big, given that GIC Re was the 12 largest reinsurer globally in 2016, according to CRISIL Research. Its international operations are spread over 160 countries and earned gross premium of Rs 10,300 crore in FY17.
The other important source of revenue for the reinsurance company is the return from investment income. This is important, given that reinsurance players fail to generate underwriting profits on a consistent basis. The company, which has over 55 per cent of its investments in equities, has generated yields of over 12 per cent over the past few years. This coupled with the fact that operating expense ratio are coming down consistently over the last few years from 133 per cent to in FY14 to 83 per cent in FY17 should help. The ratio is defined as operating expenses as a percentage of net premiums and is an indicator of operational efficiencies.
However, GIC’s risk management capabilities should help minimise the impact. The company expects to bring the ratio down to the 95-100 band over the next two years and between 90 per cent and 95 per cent over the next five years. This should help it generate net profits from core operations, rather than be dependent on investment income.
Lastly, all this comes at a decent price. The initial public offering (IPO) valuations at 1.2-1.3 times its FY17 price-to-book (including unrealised gains in investment book) are, according to analysts, reasonable and in line with global peers.
The solvency ratio, which indicates how well a company is prepared to service claims, is also reasonably high at 2.4 times in FY17. Given the potential for growth, the underwriting skills in various segments, the diversified base and an improvement in key parameters, investors could look at the issue with a medium term investment horizon.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)